Skip to content
Unither Pharmaceuticals logo — A world-leading pharmaceutical contract development manufact...

Unither Pharmaceuticals

A world-leading pharmaceutical contract development manufacturing organization (CDMO).

Founded 1993 France France 1534 employees Growth Total: $675.00M Biotechnology, Manufacturing +1

General Information

Company Name Unither Pharmaceuticals
Founded Year 1993
Location France France
Employees 1534
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Growth
Business Model B2B, White Label, B2B2B
Revenue Model Service Fee, Licensing, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Unither Pharmaceuticals. To contact Unither Pharmaceuticals, visit unither-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Unither Pharmaceuticals compare?

A PDF of Unither Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Unither Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Unither Pharmaceuticals

Unither Pharmaceuticals, founded in 1993, is a leading global player in the pharmaceutical contract development manufacturing organization (CDMO) sector, with headquarters in France. Positioned as a world leader, the company operates 8 manufacturing plants across France, the USA, Brazil, and China, along with 4 commercial offices and 1 R&D platform that enhance its expansive reach and operational capacity.

With its manufacturing prowess, Unither Pharmaceuticals specializes in innovative niche technologies, including Liquid Stick-Pack and Sterile unit-dose (Blow Fill & Seal Technology). Offering products in more than 100 countries supports an impressive annual turnover of 371 million euros.

Recently, the company secured a Growth Equity VC investment as of 01 October 2022, facilitated by key investors like GIC, Keensight Capital, and Parquest. This capital influx underscores their commitment to providing innovative, competitive, and sustainable solutions, aligning with their vision of affordable healthcare that enhances the lives of patients globally.

Business keywords: Pharmaceutical Contract Development, Manufacturing Organization, Sterile Unit-Doses, Blow Fill & Seal Technology, Liquid Stick-Pack, Multidose Formulations, Pharmaceutical Bottles, Suppositories, Pessaries, CDMO Services, Generic Pharmaceuticals, R&D Platform, Niche Technologies, Affordable Healthcare Solutions

Services & Products

Manufacturing
Development
Co-development
Regulatory Expertise
Industrial Transfer

Target Customers

Pharmaceutical Companies Biotech Start-ups Generic Drug Manufacturers Ophthalmology Product Developers Respiratory Care Product Developers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity VC Undisclosed 3
GIC, Keensight Capital +1
01 Oct 2022
Growth Equity VC Undisclosed 5
Ardian, Keensight Capital +3
01 Mar 2017
Acquisition €675.00M 1
Ardian
01 Nov 2016

Unither Pharmaceuticals Alternatives & Competitors

View All Alternatives
Unither Pharmaceuticals vs

A leading CDMO delivering aseptic fill-finish services of liquid vials, lyophilized vials, syringes,...

Series C
429 employees
Biopharma, Biotechnology
Unither Pharmaceuticals vs

Ensuring Healthier, Happier Lives

Private Equity
4911 employees
Health Care, Manufacturing
Unither Pharmaceuticals vs

Serving Sterile Health

394 employees
Manufacturing, Pharmaceutical

FAQ About Unither Pharmaceuticals

A world-leading pharmaceutical contract development manufacturing organization (CDMO).
Unither Pharmaceuticals was founded in 1993.
Unither Pharmaceuticals is headquartered in France.
Unither Pharmaceuticals operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Pharmaceutical Contract Development, Manufacturing Organization, Sterile Unit-Doses and Blow Fill & Seal Technology. Its customers include Pharmaceutical Companies, Biotech Start-ups and Generic Drug Manufacturers.
Unither Pharmaceuticals has a B2B, White Label and B2B2B business model. Its revenue comes from Service Fee, Licensing and Product Sales.
Unither Pharmaceuticals has approximately 1534 employees.
Unither Pharmaceuticals has completed 3 funding rounds, raising a total of $675.00M. The latest funding stage is Growth.
Unither Pharmaceuticals offers: Manufacturing, Development, Co-development, Regulatory Expertise, Industrial Transfer.
Top alternatives and competitors to Unither Pharmaceuticals include Grand River Aseptic Manufacturing, Akums Drugs& Pharmaceuticals Ltd, Birgi Mefar Group, Catalent, Torbay Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Unither Pharmaceuticals and Grand River Aseptic Manufacturing are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Unither Pharmaceuticals, https://bouncewatch.com/company/unither-pharmaceuticals, updated 23 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout